你知道非处方感冒药的年龄忌讳吗?_BEC初级作文

你知道非处方感冒药的年龄忌讳吗?

主持此项调查的密歇根大学儿科医生戴维斯(Matthew Davis)说，他对调查结果感到惊讶和忧虑。这一结果可能显示出，家长并不了解药品标签信息以及以往幼儿用药中出现的问题。他说：“作为家长，如果你不了解情况，你就会认为这种（药物）适合给你的孩子用。”

The medications came under close scrutiny in 2008, when the Food and Drug Administration advised that they shouldn't be given to children under 2. That came after an agency advisory committee the previous year said children younger than 6 shouldn't take the medications. The panel concluded there wasn't evidence that the drugs helped young children, while FDA safety officials had suggested some of the drugs were associated with side effects and some deaths, mostly in very young patients and often involving overdoses.

这些药品2008年开始受到严格审视，当时美国食品和药物管理局(Food and Drug Administration, 简称FDA)建议，两岁以下儿童不应该服用这些药物。在此之前一年，该机构一个顾问委员会称，六岁以下儿童不应该服用这些药物。该委员会认为，没有证据显示这些药对幼儿有效，而FDA药品安全官员曾表示，其中一些药物可能有副作用，并与部分死亡事故存在关联，这些情况主要发生在年纪很小的患者身上，而且通常是过量服用。

Manufacturers agreed to put warnings on the products' boxes that they shouldn't be given to children under 4 years old. These appear today on medications that include dextromethorphan, a cough suppressant, the expectorant guaifenesin and the decongestants phenylephrine and pseudoephedrine. Medications with antihistamines warn against use in kids younger than 6. The children's cough and cold products are sold under brand names including Novartis AG's Triaminic and Pfizer Inc.'s Dimetapp and Robitussin.